BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chao G, Ye F, Yuan Y, Zhang S. Berberine ameliorates non-steroidal anti-inflammatory drugs-induced intestinal injury by the repair of enteric nervous system. Fundam Clin Pharmacol 2020;34:238-48. [PMID: 31520444 DOI: 10.1111/fcp.12509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Cho M, Bu Y, Park J, Rahman H, Ko S. Efficacy of complementary medicine for nonsteroidal anti-inflammatory drug-induced small intestinal injuries. Medicine 2021;100:e28005. [DOI: 10.1097/md.0000000000028005] [Reference Citation Analysis]
2 Chen P, Li Y, Xiao L. Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR. Exp Ther Med 2021;22:1109. [PMID: 34504563 DOI: 10.3892/etm.2021.10543] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Chao G, Wang Q, Ye F, Zhang S. Gene expression analysis in NSAID-induced rat small intestinal disease model with the intervention of berberine by the liquid chip technology. Genes Environ 2021;43:32. [PMID: 34284820 DOI: 10.1186/s41021-021-00205-2] [Reference Citation Analysis]